Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA

D Grint; L Peters; C Schwarze-Zander; M Beniowski; C Pradier; M Battegay; D Jevtovic; V Soriano; Jens Dilling Lundgren; Jk Rockstroh; O Kirk; A Mocroft; EuroSIDA in EuroCOORD

doi:10.1111/hiv.12068

Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA

D Grint, L Peters, C Schwarze-Zander, M Beniowski, C Pradier, M Battegay, D Jevtovic, V Soriano, Jens Dilling Lundgren, Jk Rockstroh, O Kirk, A Mocroft, EuroSIDA in EuroCOORD

43 Citationer (Scopus)

Abstract

All HIV/hepatitis C virus (HCV)-coinfected patients with chronic HCV infection and ≥ F2 fibrosis should be considered for HCV therapy. This study aimed to determine the rate of HCV treatment uptake among coinfected patients in Europe.

Originalsprog	Engelsk
Tidsskrift	HIV Medicine
Vol/bind	14
Udgave nummer	10
Sider (fra-til)	614-23
Antal sider	10
ISSN	1464-2662
DOI	https://doi.org/10.1111/hiv.12068
Status	Udgivet - nov. 2013

Adgang til dokumentet

10.1111/hiv.12068

Citationsformater

@article{71a3f7a945bc472d8cb1c3294ae2ba3a,

title = "Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA",

abstract = "All HIV/hepatitis C virus (HCV)-coinfected patients with chronic HCV infection and ≥ F2 fibrosis should be considered for HCV therapy. This study aimed to determine the rate of HCV treatment uptake among coinfected patients in Europe.",

author = "D Grint and L Peters and C Schwarze-Zander and M Beniowski and C Pradier and M Battegay and D Jevtovic and V Soriano and Lundgren, {Jens Dilling} and Jk Rockstroh and O Kirk and A Mocroft and {EuroSIDA in EuroCOORD}",

note = "{\textcopyright} 2013 British HIV Association.",

year = "2013",

month = nov,

doi = "10.1111/hiv.12068",

language = "English",

volume = "14",

pages = "614--23",

journal = "HIV Medicine",

issn = "1464-2662",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "10",

}

TY - JOUR

T1 - Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA

AU - Grint, D

AU - Peters, L

AU - Schwarze-Zander, C

AU - Beniowski, M

AU - Pradier, C

AU - Battegay, M

AU - Jevtovic, D

AU - Soriano, V

AU - Lundgren, Jens Dilling

AU - Rockstroh, Jk

AU - Kirk, O

AU - Mocroft, A

AU - EuroSIDA in EuroCOORD

PY - 2013/11

Y1 - 2013/11

N2 - All HIV/hepatitis C virus (HCV)-coinfected patients with chronic HCV infection and ≥ F2 fibrosis should be considered for HCV therapy. This study aimed to determine the rate of HCV treatment uptake among coinfected patients in Europe.

AB - All HIV/hepatitis C virus (HCV)-coinfected patients with chronic HCV infection and ≥ F2 fibrosis should be considered for HCV therapy. This study aimed to determine the rate of HCV treatment uptake among coinfected patients in Europe.

U2 - 10.1111/hiv.12068

DO - 10.1111/hiv.12068

M3 - Journal article

C2 - 23869664

SN - 1464-2662

VL - 14

SP - 614

EP - 623

JO - HIV Medicine

JF - HIV Medicine

IS - 10

ER -

Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater